Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emvododstat drug-drug interaction study with dextromethorphan and rosuvastatin in healthy volunteers
NL-OMON50753Active, not recruiting
- Sponsor
- PTC Therapeutics, Inc.
- Start
- Oct 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of emvododstat, dextromethorphan and rosuvastatin in Acute Leukaemia (2 arms), sponsored by PTC Therapeutics, Inc. Primary endpoints: Dextromethorphan and dextrorphan pharmacokinetics and Rosuvastatin pharmacokinetics. Started Oct 2021; status: active, not recruiting.
02
Drugs
emvododstatdextromethorphanrosuvastatin
03
Conditions
Acute Leukaemia
Beyond the preview
Go deeper on NL-OMON50753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50753.